American CDMO Solutions that Serve Science and Our Nation.
WE DELIVER MODERN PHARMACEUTICAL DEVELOPMENT AND MANUFACTURING SOLUTIONS THAT DRIVE COST COMPETITIVENESS, HELP RESTORE AMERICA’S PHARMACEUTICAL SOVEREIGNTY, AND STRENGTHEN U.S. NATIONAL PREPAREDNESS.
Phlow’s U.S. Advanced Manufacturing Facilities.
Phlow’s state-of-the-art manufacturing infrastructure is purpose-built to support small molecule APl manufacturing scale-up for small and large clinical and commercial volumes — entirely on U.S. soil.
Protecting America’s Medicine Cabinet.
Over the past 50 years, devastating change has occurred to our global supply chain. Economic drivers moved the manufacturing of APIs, the most vulnerable component of our medicine supply chain, abroad. The changes leave our Nation vulnerable to global disruptions such as trade disputes and public health threats, price surges, and foreign inspection delays, leaving us with a depleted supply of medicines.
Phlow insisted upon change and took action with the U.S Government to rebuild a resilient domestic supply chain capable of manufacturing our most critical medicines and medical countermeasures.
1. “Review of the Food and Drug Administration’s Foreign Drug Inspection Process.” U.S. HHS Office of Inspector General, 2022.
Recent News.
Collaborate with Phlow.
Pioneering life-changing medicines all begins with a conversation. Let’s connect and make the unbelievable happen.